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Abstract
Background Incisional hernia is a frequent complication after abdominal surgery. A risk factor for incisional hernia,
related to body composition, is obesity. Poor skeletal muscle mass might also be a risk factor, as it may result in
weakness of the abdominal wall. However, it remains unknown if sarcopenia (i.e. low skeletal muscle mass) is a risk
factor for incisional hernia. Therefore, this study aims to investigate whether a relation between sarcopenia and
incisional hernia exists.
Methods Patients from the STITCH trial, who underwent elective midline laparotomy, were included. Computed
tomography examinations performed within 3 months preoperatively were used to measure the skeletal muscle index
(SMI; cm2/m2). Primarily, SMI measured continuously, sarcopenia based on previously described cut-off values for
the SMI, and sarcopenia as the lowest gender-specific SMI quartile were assessed as measures to predict incisional
hernia occurrence. Secondary, the association between these three measures and post-operative complications was
investigated.
Results In total, 283 patients (45.2% male; mean age 63.7 years; mean BMI 25.36 kg/m2) were included, of whom
52 (18%) developed an incisional hernia. Mean SMI was 44.23 cm2/m2 (SD 7.77). The Nagelkerke value for the
three measures of sarcopenia was about 0.020 (2.0%) for incisional hernia development. Logistic regressions with the
three measures of sarcopenia did not show any predictive value of the model (area under the curve (AUC) of 0.67 for
incisional hernia; 0.69 for post-operative complications).
Discussion In this study, sarcopenia does not seem to be a risk factor for the development of an incisional hernia.
Introduction
An incisional hernia is a protrusion of abdominal fat tissue,
the greater omentum or the intestines through the abdom-
inal wall, at the site of a surgical incision [1]. Incisional
hernias may cause discomfort, pain, and reduction of
quality of life [2]. In the USA alone, nearly 350,000 hernia
repairs are performed annually, costing approximately $3
billion dollars [3].
A great number of studies have been conducted to assess
the optimal closing technique for midline incision laparo-
tomies, but the risk of incisional hernia remains about
5-20% [4–6].
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Major risk factors for incisional hernia, such as obesity,
high age, infection, chemotherapy, and smoking, are well
known [6–12]. Sarcopenia is the progressive decline of
muscle mass, which results in decreased functional
capacity of the muscles [13]. It could be a potential risk
factor for incisional hernia, as it may result in weakness of
the abdominal wall. However, no studies up to now have
been done to assess this potential predictor.
In oncological surgery, however, sarcopenia is a rela-
tively newly discovered risk factor. It can be measured at
the level of the third (L3) or fourth lumbar vertebra (L4).
When sarcopenia is measured as total skeletal muscle
cross-sectional area (CSA) at the level of the third lumbar
vertebra (L3), it is associated with a lower long-term sur-
vival in patients undergoing colorectal cancer resection
[14, 15], in patients with colorectal liver metastasis [16],
and in patients undergoing hepatectomy for hepatocellular
carcinoma [17, 18]. Additionally, sarcopenia measured as
CSA on L3 can predict post-operative complications
[18–20] and is associated with a longer length of stay after
surgery [19].
When sarcopenia is measured at the level of the fourth
lumbar vertebra (L4), through psoas muscle measurement,
it approximates lean core muscle mass. This psoas muscle
measurement is associated with mortality in patients
undergoing liver transplantation [21], abdominal aortic
aneurysm repair [22], emergency abdominal surgery [23],
and in patients after the resection of a pancreatic adeno-
carcinoma [24]. Moreover, sarcopenia through psoas
muscle measurement is associated with morbidity and can
predict post-operative complications in several patient
groups [25–27].
A systematic review endorsed the above-mentioned
findings; sarcopenia is associated with an increased number
of post-operative complications and an increased long-term
mortality ([1 year) after abdominal surgery [28].
There is only limited knowledge on the relation between
sarcopenia and post-operative outcomes after ventral her-
nia repair [29, 30]. The presence or absence of an associ-
ation of sarcopenia with the occurrence of incisional hernia
after elective midline laparotomy has not been described.
Therefore, we assessed the predictive value of sarcopenia
for the occurrence of incisional hernia. We hypothesized
that patients with sarcopenia will have a higher incidence
of incisional hernia after surgery.
Materials and methods
Study design and data acquisition
Patients who underwent elective midline laparotomy in
four of the participating hospitals of the STITCH trial were
included [31]. The STITCH trial is a multicentre, ran-
domized controlled trial, performed from October 2009 to
March 2012, in 545 patients 18 years or older undergoing
elective midline laparotomy. The trial compared small
bites with big bites for abdominal closure, with incisional
hernia as the primary outcome measure. Excluded from
participation were patients with a history of incisional
hernia or fascia dehiscence after a midline laparotomy,
patients who had undergone abdominal surgery through a
midline incision within the past 3 months, patients who
were pregnant, or patients participating in another inter-
vention trial [31]. Included patients had at least one follow-
up visit up to 15 months after surgery. Incisional hernia
was diagnosed by physical examination, ultrasound imag-
ing, or both.
Preoperative CT examinations (within 3 months before
surgery) of the STITCH trial patients were collected and
anonymized before assessment. Data regarding predictive
parameters for incisional hernia (i.e. the closure method
used in the STITCH trial, age, smoking status, diabetes
mellitus, body mass index (BMI), and gender) were
extracted from the trial database.
Sarcopenia assessment
The presence of sarcopenia was assessed with the method
previously described by Vledder et al. [16]. Skeletal mus-
cle mass was measured at the level of the third lumbar
vertebra (L3), on which both the processi transversi were
visible. By manual outlining of the skeletal muscle, the
cross-sectional area (CSA) in cm2 was automatically cal-
culated based on a Houndsfield unit (HU) threshold for
muscle (-30 HU to ?150 HU). The obtained CSA was
then adjusted for patients’ height squared (m2), resulting in
the skeletal muscle index (SMI; cm2/m2).
Additional to the continuous measure SMI, two other
measures for muscle mass were used to explore the effect
of low skeletal muscle mass compared to high skeletal
muscle mass in patients. The first measure was established
using the cut-off values described by Martin et al. [32]
(\41 cm2/m2 for females, \43 cm2/m2 for males with a
BMI\ 25, and\53 cm2/m2 for males with a BMI[ 25);
patients were divided in a sarcopenia and non-sarcopenia
group. The second measure was the creation of gender-
specific quartiles; patients in the lowest gender-specific
quartile were considered to have sarcopenia.
Outcome measures
The primary outcome measure for the study was the
development of an incisional hernia. In order to assess
whether sarcopenia is a risk factor for incisional hernia
development, patients with a follow-up of less than
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6 months were excluded from the analysis; it is unlikely
that this time frame is sufficiently long to observe inci-
sional hernia development.
The secondary outcome measure was the occurrence of
post-operative complications.
Statistical analysis
Categorical data are reported as counts and percentages;
continuous data are either reported as means with standard
deviation (SD) or median with interquartile range (IQR).
Means were compared with a Chi-square test, medians with
a Mann–Whitney U test. A logistic regression model for
the primary outcome was created to assess the predictive
value of the three muscle mass measurements (continuous
SMI, gender-specific quartiles, and cut-offs based on
Martin et al. [32].). We controlled for known risk factors
for incisional hernia: age, gender, BMI, smoking status,
diabetes, and the closure method during the surgery, since
small bites showed a significantly better result in the
STITCH trial. The 95% confidence intervals of the AUCs
were calculated by bootstrapping.
To predict the occurrence of post-operative complica-
tions, another logistic regression model was created, con-
trolling again for age, gender, BMI, smoking status,
diabetes, and the closure method, and additionally for ASA
(American Society of Anesthesiologists) classification,
blood loss during surgery, wound length, and the presence
of cardiovascular comorbidities.
Statistical analyses were performed using RStudio ver-
sion 1.0.136 (RStudio, Inc.) and SPSS 24.0.0.0 (IBM
Corporation).
Results
Patient characteristics
A total of 502 of the STITCH patients were treated in the
four hospitals participating in our study (Fig. 1). Of these
patients, 286 (57%) had a preoperative CT examination
available within 3 months before surgery. On three CTs,
the CSA was not measurable due to the low quality of the
images or the incomplete visibility of the muscles of
interest; these patients were excluded from the analysis.
The remaining 283 patients form the study cohort, of
which 52 patients (18%) developed an incisional hernia.
The number of patients undergoing surgery for a malignant
disease was comparable between and within both groups.
Baseline characteristics of these patients are shown in
Table 1.
Prevalence of sarcopenia
Sarcopenia determined through the lowest gender-specific
quartile resulted, by definition, in 25.0% of males and
25.2% of females having sarcopenia. The cut-off values of
SMI were determined on 43.3 cm2/m2 for males and
36.5 cm2/m2 for females. When sarcopenia was determined
through the cut-off values of Martin et al. [32], 43.8% of
males and 59.4% of females were considered sarcopenic.
The average SMI for males was 49.0 cm2/m2 and for
females 40.3 cm2/m2 (Table 2).
Hernia development
When sarcopenia was measured through the lowest gender-
specific quartile, 18.8% of people with sarcopenia
Fig. 1 Flow chart of included
patients
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developed a hernia, compared to 18.6% of people without
sarcopenia.
When sarcopenia was measured through cut-off values
from the literature, 19.9% of people with sarcopenia
developed a hernia, compared to 17.3% of people without
sarcopenia.
Three different logistic regression models were devel-
oped with hernia as dependent outcome variable, and with
continuous SMI (model 1); sarcopenia based on literature
cut-offs (model 2); and sarcopenia as the lowest gender-
specific quartile (model 3) as independent variables
(Table 3).
The models rendered a Nagelkerke value of approxi-
mately 0.135; this means that 13.5% of the variation in the
occurrence of incisional hernias is explained by the
covariates. The Nagelkerke value for the specific sar-
copenia measures was approximately 0.020, meaning that
sarcopenia accounted for approximately 2.0% of the vari-
ation in occurrence of incisional hernias (Table 4).
In Fig. 2, the created logistic regression models are
depicted in a receiver operating characteristic (ROC)
curve. The black curve is a model without any sarcopenia
measure.
The corresponding AUC values with 95% confidence
intervals (CI) are in Table 4.
Post-operative complications
Logistic regression models were also created with post-
operative complications as dependent outcome variable. In
total, 124 (43.8%) patients developed a post-operative
complication. These included post-operative ileus, pneu-
monia, cardiac complications, urinary tract infection, hae-
matoma, surgical site infection (SSI; superficial, deep, or
organ), seroma, and burst abdomen. Again, three models
were created, in the same way as for the hernia occurrence,
only controlling for more independent variables.
Table 1 Baseline characteristics per sarcopenia group, expressed in mean (SD) or n (%)
Characteristics Lowest gender-specific quartile According to Martin et al. [32]
No sarcopenia n = 212 Sarcopenia n = 71 p value No sarcopenia n = 135 Sarcopenia n = 148 p value
Gender 0.975 0.009
Male 96 (45.3%) 32 (45.1%) 72 (53.3%) 56 (37.8%)
Female 116 (54.7%) 39 (54.9%) 63 (46.7%) 92 (62.2%)
Age (years) 63.1 (12.8) 65.5 (13.0) 0.174 62.0 (12.9) 65.3 (12.7) 0.030
BMI (kg/m2) 26.2 (4.5) 22.9 (3.7) \ 0.001 26.4 (4.8) 24.4 (4.1) \0.001
Smoking 46 (21.7%) 10 (14.1%) 0.319 34 (25.2%) 22 (14.9%) 0.051
Diabetes 32 (15.1%) 11 (15.5%) 0.935 24 (17.8%) 19 (12.8%) 0.248
Cardiovascular disease 87 (41.0%) 28 (39.4%) 0.812 52 (38.5%) 63 (42.6%) 0.489
ASA 0.036 0.593
1 53 (25.0%) 8 (11.3%) 31 (23.0%) 30 (20.3%)
2 122 (57.5%) 45(63.4%) 81 (60.0%) 86 (58.1%)
C3 37 (17.5%) 18 (25.4%) 23 (17.0%) 32 (21.6%)
Closure method 0.919 0.069
Large bites 109 (51.4%) 37 (52.1%) 62 (45.9%) 84 (56.8%)
Small bites 103 (48.6%) 34 (47.9%) 73 (54.1%) 64 (43.2%)
Blood loss (L)a 0.6 (1.00) 0.4 (0.85) 0.087 0.6 (1.14) 0.5 (0.88) 0.225
Wound length (cm) 22.2 (4.7) 22.0 (5.2) 0.814 22.5 (4.6) 21.9 (5.0) 0.346
SMI (cm2/m2) 46.9 (6.8) 36.2 (4.0) \0.001 39.4 (5.5) 49.5 (6.4) \0.001
Follow-up time (months)a 12 (11–14) 13 (12–15) 12 (11.5–13) 12 (12–15)
aMedian (IQR)
Table 2 Average continuous SMI measures in cm2/m2 (mean, stan-
dard deviation)
Males Females
N = 128 N = 155
SMI (mean, SD) 49.0 (7.3) 40.3 (5.7)
Lowest gender-specific quartile (SMI)
No sarcopenia 52.1 (5.4) 42.6 (4.5)
Sarcopenia 39.6 (3.0) 33.5 (2.2)
According to Martin et al. (SMI)
No sarcopenia 52.9 (6.0) 45.6 (4.1)
Sarcopenia 43.9 (5.6) 36.7 (3.3)
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Model 1 again shows the continuous SMI (green), model
2 sarcopenia based on literature cut-offs (red), model 3
sarcopenia based on gender-specific quartiles (purple), and
the black line shows a model without any of the sarcopenia
measures (Fig. 3).
The corresponding Nagelkerke, AUC, and OR values
can be found in Table 5.
Discussion
Our results point towards a lack of an association between
sarcopenia and incisional hernia. According to Nagelk-
erke’s R2, sarcopenia has a 1.0–2.7% share in the variation
in occurrence of incisional hernia. This seems rather a lot
when the total model seems to explain at maximum 14% in
the variation of incisional hernia occurrence. However,
none of the produced models rendered an AUC value of
over 0.70, which is considered the cut-off value for
acceptable discrimination.
Despite the low AUCs, the Nagelkerke’s R2 of 0.14 is
interesting.Many authors have identified the same risk factors
for incisional hernia, such as obesity (high BMI) and smoking
[6, 8–11]. Having included the largest, most commonly
identified risk factors inourmodels,wewould haveexpecteda
much higher proportion of variation in incisional hernia
occurrence to be explained by the variables in the model.
Table 3 Obtained odds ratios (OR) and their respective 95% confidence intervals (CI) from the three models. Model 1 with continuous SMI,
model 2 with sarcopenia based on literature cut-offs, and model 3 with sarcopenia as lowest gender-specific quartile
Variable Model 1 Model 2 Model 3
OR 95% CI OR 95% CI OR 95% CI
Closure method 0.50 0.25–0.98 0.51 0.26–1.00 0.48 0.24–0.94
Age 1.02 0.99–1.05 1.02 0.99–1.05 1.02 0.99–1.05
Smoking 1.94 0.81–4.55 1.82 0.76–4.22 1.78 0.75–4.11
Diabetes mellitus 1.52 0.53–4.09 1.57 0.55–4.21 1.42 0.50–3.77
BMI 1.09 1.00–1.20 1.05 0.97–1.14 1.07 0.98–1.16
Gender 0.48 0.20–1.16 0.78 0.39–1.55 0.85 0.43–1.68
SMI 0.94 0.88–1.00
Sarcopenia 1.52 0.76–3.12 2.08 0.89–4.79
Table 4 Nagelkerke values and AUC values of the created ROC
curves for incisional hernia prediction
Nagelkerke
total
Nagelkerke
sarcopenia
factor
AUC (95% CI)
Model 1 0.1396 0.027 0.6690 (0.5814–0.7510)
Model 2 0.1250 0.010 0.6538 (0.5703–0.7330)
Model 3 0.1346 0.021 0.6670 (0.5787–0.7521)
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Fig. 2 ROC curves of model 1 (continuous SMI, green); model 2
(sarcopenia literature cut-offs, red); and model 3 (sarcopenia
gender-specific quartile, purple) for the prediction of incisional
hernia. The black line corresponds to a logistic regression model
without any sarcopenia measure
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Fig. 3 ROC curves of model 1 (green); model 2 (red); and model 3
(purple) for the prediction of post-operative outcomes. The black
line corresponds to a logistic regression model without any
sarcopenia measure
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Concerning the secondary outcomes, our results point
towards the absence of predictive value of sarcopenia for
the development of post-operative complications. A recent
publication endorses our finding, not showing a relation
between post-operative outcomes and sarcopenia in
patients undergoing ventral hernia repair [29]. It states that
most muscle index cut-offs were validated in patients with
cancer [14, 32] and might therefore not be applicable to
non-malignant patients. Patients with malignancy and liver
disease could have differences in metabolic state, hor-
monal, pharmacological, and endocrine factors, resulting in
a difference in post-operative outcomes compared to non-
malignant patients.
However, in the population pool for our study, most
patients had malignant disease. Then, the absence of pre-
dictive value of sarcopenia is contradictory to previous
findings; multiple studies describe the importance of sar-
copenia for the development of post-operative complica-
tions in oncological surgery [18, 19, 25, 27]. However,
most of these studies included a number of consecutive
patients, whereas we used patients that were randomized
for a trial on surgical techniques. In randomized controlled
trials (RCT), patients are selected differently: if patients are
too frail, they might not be invited, or might not want to
participate. So, whereas previous research in malignant
patients stresses the importance of sarcopenia as a predictor
of post-surgical outcomes, we have found little to no pre-
dictive value of sarcopenia.
Limitations
A limitation of sarcopenia studies, in general, is the limited
comparability between studies due to the methods used for
measuring or defining sarcopenia. Sarcopenia is often
defined and measured differently, for example low muscle
strength measured as low handgrip strength or abnormal
body composition measured with bioimpedance [13]. Our
study, in which sarcopenia is based on the SMI, is not
comparable to studies using other definitions or
measurements.
In our study, a limitation might be that we have used
logistic regression instead of Cox regression. Cox regres-
sion is meant for outcome development over time, while
logistic regression focuses on outcomes on one point in
time. However, our data come from the STITCH trial, in
which hernia occurrence was measured 12 months after
surgery. Some people could have developed the hernia at
an earlier point in time, but hernias were only registered
when patients actively came to the doctor with a developed
hernia, or when a hernia was diagnosed during a follow-up
visit of the study. Therefore, we decided it would be better
to not look at the time-to-event with Cox regression, but to
use logistic regression.
Another limitation might be that we looked at CT scans
up to 3 months before surgery. Within 3 months, muscle
quantity can increase or decrease significantly. Patients not
having sarcopenia 3 months before surgery could possibly
be sarcopenic at the time of surgery. They would have been
included in the wrong group in our study. Three months,
however, is not an uncommon timeframe [18, 21, 22] and
can increase comparability with other literatures.
With regard to post-operative examinations, hernias
were diagnosed through physical examination, ultrasound,
or both. No post-operative CT examinations were done for
hernia assessment in the STITCH trial. According to a
recent review, it remains unclear whether CT examinations
have an additional benefit to ultrasound examinations [33].
Moreover, it can be argued that more risk factors should
have been added to the model for incisional hernia. How-
ever, the relatively limited number of patients hindered
investigating more predictors such as chronic obstructive
pulmonary disease (COPD) or aneurysms of the abdominal
aorta (AAA); in our current models, this would have led to
overfitting. Also no adjustment took place for other oper-
ative risk factors, such as spillage.
In our database, sarcopenia and BMI were highly cor-
related (Spearman’s rank correlation of 0.48). This is vis-
ible in the significant difference in baseline BMI between
sarcopenia groups in Table 1 and also found by other
authors [29]. We adjusted for BMI in our models, to show
the additional value of sarcopenia. This positive correlation
is interesting; while a high BMI is related to worse post-
operative outcomes, the effect estimate of SMI shows a
protective effect for developing an incisional hernia. When
patients with a BMI between 25 and 30 gain weight, usu-
ally they gain both muscle and either visceral or subcuta-
neous fat. The real danger is for patients with sarcopenic
obesity, having a high BMI, but a low SMI. Multiple
studies show this as well [14, 25, 34].
Table 5 Nagelkerke values, AUC values, and OR values of the created models and ROC curves for post-operative complication prediction
Post-operative outcomes Nagelkerke total Nagelkerke sarcopenia factor AUC (95% CI) OR (95% CI) of sarcopenia measure
Model 1 0.1832 0.000 0.6927 (0.6310–0.7563) 0.99 (0.94–1.04)
Model 2 0.1845 0.002 0.6912 (0.6335–0.7485) 1.18 (0.69–2.06)
Model 3 0.1855 0.003 0.6941 (0.6300–0.7580) 1.28 (0.68–2.42)
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Implications
Measurement of CT scans for SMI is very labour-intensive,
but it does not seem to have significant predictive value.
Since it is highly correlated with BMI, we would suggest
using BMI, because it is easier to determine and to use in
practice.
The low AUCs make our models questionable in pre-
dicting hernia development and post-operative complica-
tion development. However, we included the largest, most
commonly acknowledged risk factors. This could suggest
that there are other, large, and unknown risk factors for the
development of incisional hernia that have yet to be
discovered.
Conclusion
Despite the current interest in sarcopenia, which is shown
to be useful in oncological surgery research, sarcopenia
might not have much predictive value in the development
of incisional hernia. Our models with low AUC values
indicate that further research should be conducted to other
potential risk factors. Measurement of sarcopenia through
CT scans seems, for now, too labour-intensive for its
respective returns, and clinicians could better use currently
known risk factors.
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